Extracellular domain of TGFβ type III receptor inhibits angiogenesis and tumor growth in human cancer cells
Data up to Jan 2025
Total Citations Per Year
Abstract
References (41)
Antibodies, a laboratory manual
1989 • 12,929 citations
Angiogenesis in cancer, vascular, rheumatoid and other disease
1995 • 7,717 citations
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
1996 • 6,878 citations
Antibodies: A laboratory manual
1989 • 4,532 citations
Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.
1987 • 3,809 citations
The Transforming Growth Factor-beta Family
1990 • 3,028 citations
Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.
1986 • 2,878 citations
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
2000 • 2,354 citations
Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma
1982 • 1,225 citations
Anti-Angiogenesis
1972 • 1,167 citations
TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development
1999 • 969 citations
Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
2001 • 854 citations
Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system
1991 • 661 citations
TGFβ signaling is necessary for carcinoma cell invasiveness and metastasis
1998 • 630 citations
Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice.
1990 • 617 citations
Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix.
1988 • 571 citations
Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane.
1990 • 470 citations
Tumor suppressor activity of the TGF-β pathway in human cancers
1996 • 412 citations
Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.
1990 • 398 citations
Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression.
1993 • 356 citations
Membrane-anchored and soluble forms of betaglycan, a polymorphic proteoglycan that binds transforming growth factor-beta.
1989 • 346 citations
Demonstration That Mutation of the Type II Transforming Growth Factor β Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells
1995 • 340 citations
Defective repression of c- myc in breast cancer cells: A loss at the core of the transforming growth factor β growth arrest program
2001 • 320 citations
Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression.
1997 • 284 citations
Differential effects of laminin, intact type IV collagen, and specific domains of type IV collagen on endothelial cell adhesion and migration.
1988 • 237 citations
Enhanced Tumor Growth of Both Primary and Established Human and Murine Tumor Cells in Athymic Mice After Coinjection With Matrigel
1991 • 216 citations
Heterogeneity of human colon carcinoma
1984 • 165 citations
Metastasis from human breast cancer cell lines
1996 • 159 citations
Ligand Binding and Functional Properties of Betaglycan, a Co-receptor of the Transforming Growth Factor-β Superfamily
2001 • 148 citations
Excessive production of transforming growth-factor β1 can play an important role in the development of tumorigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumor growth
1992 • 147 citations
A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells.
1999 • 116 citations
TGF-β and cancer
1999 • 115 citations
Expression of Scatter Factor in Human Bladder Carcinoma
1995 • 107 citations
Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-β neutralizing agent
2001 • 86 citations
Transforming growth factor beta1 induces angiogenesis in vivo with a threshold pattern.
1996 • 85 citations
Transforming growth factor β and cancer
1995 • 73 citations
Expression of Transforming Growth Factor β Type III Receptor Suppresses Tumorigenicity of Human Breast Cancer MDA-MB-231 Cells
1997 • 69 citations
Comparison of growth requirements of two human intratumoral colon carcinoma cell lines in monolayer and soft agarose.
1988 • 69 citations
Expression of Transforming Growth Factor β (TGFβ) Type III Receptor Restores Autocrine TGFβ1 Activity in Human Breast Cancer MCF-7 Cells
1997 • 58 citations
Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-β neutralizing agent
2001 • 55 citations
Potentiation of Metastatic Capacity by Transforming Growth Factor‐β1 Gene Transfection
1993 • 30 citations